Healthy.io Acquires Labrador Health, Advancing the Future of At-Home Kidney Diagnostics
This strategic acquisition marks a step forward in Healthy.io's mission of transforming home-based diagnostics with lab-quality accuracy, powered by the smartphone. By integrating Labrador Health's technology with Healthy.io's FDA-cleared and CE-marked suite of products already available globally, the company is poised to launch the next generation of quantitative at-home kidney testing, expanding access to high-quality diagnostics around the world.
The team is already collaborating on developing the first ever quantitative, home-based ACR test - expected to launch in 2026. This home test is designed to tackle the significant global care-gap in Chronic Kidney Disease. With its novel quantitative features, the product will align with existing care-pathways and international reimbursement schemes, while making testing more accessible and routine - enabling earlier detection and better outcomes at scale.
As part of the integration, all Labrador team members will be joining Healthy.io. At the same time, the company is sharpening its focus on scalable, high-impact offerings by realigning internal resources to accelerate commercialization and innovation in its core markets. This renewed focus will support continued growth of Healthy.io's existing semi-quantitative product while driving the development of next-generation diagnostics enabled by the newly acquired technology.
"This acquisition is about accelerating our mission to deliver clinical-grade testing from the comfort of home," said
"With just
Addressing the Growing Need for Early Kidney Disease Detection in the
Chronic Kidney Disease (CKD) affects over 35 million Americans, yet millions remain undiagnosed. Traditional testing methods often limit access and adherence, especially in at-risk communities. Healthy.io's at-home semi-quantitative tests have already proven effective in improving access and early detection. The addition of Labrador's quantitative technology offers even greater clinical insight and empowers better disease management.
A New Chapter in Home-Based Diagnostics
This combination represents a step-change in the accessibility and quality of at-home testing. By uniting Labrador's innovation with Healthy.io's computer vision technologies and operational scale, the companies are poised to redefine how kidney health is monitored and managed—bringing precise, proactive care directly into the hands of patients worldwide.
About Healthy.io
Healthy.io transforms smartphone cameras into clinical-grade diagnostic tools. Its solutions support at-home testing for chronic kidney disease, urinary tract infections, and wound care, reducing barriers to care and driving meaningful health outcomes. Healthy.io partners with leading health systems and retailers across the
About Labrador Health
Labrador Health developed a cutting-edge platform for quantitative urine testing, combining proprietary biochemistry and microfluidics, and computer vision technologies to deliver lab-grade results at home. The company has partnered with leading clinical institutions to validate its solution, and its technology has received strong interest from both the clinical and investor communities. Founded in 2021 by
Contact: [email protected]
Logo: https://mma.prnewswire.com/media/1856865/5290503/Healthy_io_Logo.jpg
View original content to download multimedia:https://www.prnewswire.com/news-releases/healthyio-acquires-labrador-health-advancing-the-future-of-at-home-kidney-diagnostics-302439978.html
SOURCE Healthy.io
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CFOs Turn to AI to Better Synchronize Finance and Enterprise Priorities, Report AI ROI Challenges: Protiviti Global Finance Trends Survey
- Record Sale in Prestigious Forest Hill Sets New Toronto Real Estate Benchmark
- Dimensional Fund Advisors Ltd. : Form 8.3 - SPIRE HEALTHCARE GROUP PLC - Ordinary Shares
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Definitive Agreement, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share